Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Larimar Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 136 | +21 |
| Shares | 62.3M | 237.8K | 85.5M | +23.4M (+37.7%) |
| Value | $180.1M | $687.2K | $274.8M | +$95.4M (+53.2%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Larimar Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (9)
Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Oconnor LLC | 307,198 | $887.8K |
| Assenagon Asset Management S.A. | 256,861 | $742.3K |
| Wexford Capital LP | 69,799 | $201.7K |
| State of Wisconsin Investment Board | 31,515 | $91.1K |
| Algert Global LLC | 29,030 | $83.9K |
| Keystone Financial Group | 13,000 | $37.6K |
| Voya Investment Management LLC | 12,092 | $34.9K |
| Raymond James Financial Inc | 8,000 | $23.1K |
| GWM Advisors LLC | 4,121 | $11.9K |
Not filed for Q3 2025 yet (1)
Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| HAP Trading, LLC | 237,776 | $687.2K |